Mind & Mood
Alzheimer's drug update
Harvard researchers help test new drugs that could strike at the root of Alzheimer's disease. Here's where things stand.
In October 2012, scientists at the American Neurological Association (ANA) meeting in Boston presented the latest findings on a new generation of Alzheimer's medications. These drugs are designed to fight the build-up of abnormal amyloid protein in the brains of people with Alzheimer's disease. Experts hope that blocking amyloid will delay or possibly even stop the progression of the illness.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.